Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1321–1344 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Heart Failure
Interventions: CRT-D (Intra-thoracic Impedance Monitoring); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 7
States / cities: Little Rock, Arkansas • Pasadena, California • Colorado Springs, Colorado + 4 more

Conditions: Vascular Access Complications
Interventions: AccuCath IV Catheter System, Conventional IV Catheter System; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Androgenetic Alopecia, Hair Loss, Male Pattern Baldness
Interventions: HairMax LaserComb 2009, 7 Beam, HairMax LaserComb; Device
Lead sponsor: Lexington International, LLC; Industry
Eligibility: 25 Years to 60 Years · Male only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Palm Beach, Florida • Austin, Texas

Conditions: Cancer, Diabetes
Interventions: Fitbit, Continuous Glucose Monitor; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Technical Sucess, Freedom From Type I and III Endoleaks at 12 Months, Freedom From Stent Graft Migration at 12 Months, Freedom From Aortic Aneurysm Enlargement at 12 Months, Freedom From Aortic Aneurysm Rupture or Conversion to Open Repair at 12 Months
Interventions: Physician Modified Endografting; Device
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Rheumatoid Arthritis, Osteoarthritis Shoulder, Fractures Humerus, Avascular Necrosis, Correction of Functional Deformity, Traumatic Arthritis, Revision of Other Devices if Sufficient Bone Stock Remains, Rotator Cuff Tears
Interventions: Tornier HRS (HUMERAL RECONSTRUCTION SYSTEM) shoulder system; Device
Lead sponsor: Stryker Trauma and Extremities; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2036
U.S. locations: 4
States / cities: Denver, Colorado • Bradenton, Florida • Tampa, Florida + 1 more

Conditions: Adverse Effect of MRI on an Implanted Pacemaker Lead, Adverse Effect of MRI on an Implanted Pacemaker
Interventions: Accent MRI system (lead safety), Accent MRI system (with MRI scan); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: Not listed
Enrollment: 950 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 66
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 57 more

Conditions: Spinal Cord Injuries, Spinal Cord Injury at C5-C7 Level, Spinal Cord Injury Cervical, Spinal Cord Injury at C5-C7 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Incomplete Lesion
Interventions: Networked Neuroprosthetic System for Grasp and Trunk; Device
Lead sponsor: Anne Bryden; Other
Eligibility: 17 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2031
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Spinal Cord Injuries, Constipation, Fecal Incontinence, Neurogenic Bowel
Interventions: Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics; Drug · Device
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Quality of Life, Catheter-Associated Urinary Tract Infection
Interventions: Active UroShield, Sham UroShield; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Saline, Michigan

Conditions: Retinal Disease
Interventions: Electroretinography; Diagnostic Test
Lead sponsor: Diopsys, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Tahlequah, Oklahoma

Conditions: Heart Failure
Interventions: Paradym CRT 8770; Device
Lead sponsor: LivaNova; Industry
Eligibility: 18 Years and older
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 5
States / cities: Kaplan, Phoenix,, Arizona • Siegel, Phoenix,, Arizona • Boston, Massachusetts + 2 more

Conditions: Heart Failure, Gastrointestinal Bleeding
Interventions: Omega 3 fatty acids, Placebo; Drug · Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Normal Physiology
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight, Hypertension, Cardiovascular Disease Acute, Hyperlipidemia, Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD, Peripheral Artery Disease, Metabolic Syndrome, Prediabetes
Interventions: Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent; Device · Drug
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Fatigue, Metastatic Breast Carcinoma
Interventions: Apollo Armband; Device
Lead sponsor: Margaret Quinn Rosenzweig; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stroke, Transient Ischemic Attack
Interventions: Septal Occluder Device, Antiplatelet Medical Therapy; Device · Drug
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 664 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bilateral Nasal Polyposis
Interventions: Fluticasone Propionate; Drug
Lead sponsor: Optinose US Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 30
States / cities: Tucson, Arizona • Bakersfield, California • Fresno, California + 25 more

Conditions: Heart Failure
Interventions: Simulation-based Mastery Learning (SBML); Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COVID-19, Acute Respiratory Infection
Interventions: Not listed
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland • Durham, North Carolina

Conditions: IV Infiltration, IV Extravasation
Interventions: non-invasive thermal infusion site monitoring NTISM device; Device
Lead sponsor: Rhaeos, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Left Ventricular Assist Device, Percutaneous Lead Management
Interventions: Percutaneous Lead Management Kit; Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 16 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 5
States / cities: Birmingham, Alabama • San Diego, California • Ann Arbor, Michigan + 2 more

Conditions: Pain
Interventions: Heating device (Heatwave Technology); Device
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Atrial Fibrillation, Congestive Heart Failure
Interventions: Protos DR/CLS and Stratos LV CRT pacemakers; Device
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 10
States / cities: Birmingham, Alabama • Lake Charles, Louisiana • Boston, Massachusetts + 7 more

Search by objective public record fields.

Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices

Comparison of AccuCath IV Catheter and Conventional IV Catheter in Interventional Radiology

Treatment of Androgenetic Alopecia in Males

Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices

Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms

Tornier HRS (Humeral Reconstruction System) Study (REVIVE)

Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead

Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury

Transdermal Administration by a Novel Wireless Iontophoresis Device

Evaluation of Quality-of-Life Improvements Using UroShield Device

Study to Compare the Diopsys NOVA and LKC RETeval Devices

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device

Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD

Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses

Truway Diagnostic Tools in Primary Care

Apollo Device for Metastatic Breast Cancer (MBC)

GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

Use of Simulation to Improve VAD Self-management

Prophylaxis and Treatment of COVID-19

Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study

Safety of Pulsing Heating Device Use on the Skin

Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace